EMA Advises Limited Use of Celltrion COVID-19 Antibody Drug, Says Benefits Still Unclear On 2021-03-31 (Reuters) – Europe’s drug regulator said on Friday South Korean drugmaker Celltrion’s COVID-19 treatment can be considered for patients at […]
IDSA Updates COVID-19 Treatment Guidelines: Monoclonals and More On 2021-03-19 Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. While there is still no “game-changer” […]
EU Regulator Advises on Use of Lilly’s COVID-19 Antibody Cocktail On 2021-03-08 (Reuters) – Europe’s medicines regulator said on Friday Eli Lilly and Co’s antibody drug combination can be used to treat […]
Relapsed/Refractory Follicular Lymphoma Research On 2021-01-31 A defining characteristic of relapsed or refractory follicular lymphoma (RRFL) is the presence of repeated recurrences and the need for […]